Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1446194 BALA CYNWYD, PA
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,189,249
+$3,850,996 QoQ
Shares Held
16,417
+144.9% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#108
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Derivatives in LGND

reported options exposure · as of Jun 30, 2026
CallValue
$4,962,613
CallShares
15,700
PutValue
$10,304,534
PutShares
32,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. LGND ranks #47 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in LGND

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,189,249 16,417
2026-06-30 $10,304,534 32,600
2026-06-30 $4,962,613 15,700
2026-03-31 $1,338,253 6,703
2026-03-31 $1,597,200 8,000
2026-03-31 $3,573,735 17,900
2025-12-31 $1,022,679 5,409
2025-12-31 $529,396 2,800
2025-12-31 $2,325,561 12,300
2025-09-30 $336,566 1,900
2025-09-30 $1,594,260 9,000
2025-09-30 $1,560,071 8,807
2025-06-30 $625,240 5,500
2025-06-30 $3,303,540 29,060
2025-03-31 $714,952 6,800
2025-03-31 $2,393,512 22,765
2024-12-31 $1,317,945 12,300
2024-12-31 $815,840 7,614
2024-09-30 $1,740,764 17,392
2024-09-30 $1,351,215 13,500
2024-06-30 $556,116 6,600
2024-06-30 $2,940,674 34,900
2024-06-30 $1,011,035 11,999
2024-03-31 $1,023,400 14,000
2024-03-31 $1,097,523 15,014
2024-03-31 $3,618,450 49,500
2023-12-31 $878,466 12,300
2023-12-31 $1,506,962 21,100
2023-12-31 $1,091,011 15,276
2023-09-30 $862,848 14,400
2023-09-30 $673,740 11,244
2023-09-30 $1,833,552 30,600
2023-06-30 $496,552 6,887
2023-06-30 $1,679,930 23,300
2023-06-30 $2,393,720 33,200
2023-03-31 $2,986,536 40,600
2023-03-31 $522,864 7,108
2023-03-31 $389,868 5,300
2022-12-31 $607,880 9,100
2022-12-31 $856,309 12,819
2022-09-30 $4,977,155 57,800
2022-09-30 $1,353,992 15,724
2022-09-30 $387,494 4,500
2022-06-30 $2,498,158 28,000
2022-06-30 $383,645 4,300
2022-03-31 $3,914,653 34,800
2022-03-31 $2,373,539 21,100
2022-03-31 $1,404,100 12,482
2021-12-31 $2,150,236 13,921
2021-12-31 $2,672,157 17,300